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Recently, the topic of addressing clinical relevance on
the top of statistical significance in the analysis of RCTs
has been paid increasing attention. Several formal cri-
teria to serve this purpose have been published.
In this talk we present a framework which allows to
investigate the impact of applying such formal criteria,
independent of the scale of the outcome variable. The
only assumption made is that we have one clinical trial
correctly powered to achieve a 90% power. All treatment
effects are then expressed as fractions of the assumed
effect.
In a first step we quantify the actual risk of having
accepted a treatment with an irrelevant effect in a suc-
cessful RCT, and we find this risk to be often rather
small. In a second step we investigate two popular cri-
teria based on comparing the effect estimate or the
lower bound of the confidence interval with a given
threshold. We demonstrate their equivalence in large
samples and quantify the impact of applying them in
terms of decreasing the risk of accepting a treatment
with an irrelevant effect and increasing the risk of failing
to accept a treatment with a relevant effect.
Putting weights on these two types of errors, we can
demonstrate that the formal criteria do often more harm
than good. We discuss implications of these results on
adapting sample sizes to demonstrate clinical relevance
and on the application of the formal criteria if several stu-
dies are summarized in a meta-analysis.
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